Best TWAS P=3.28e-10 · Best GWAS P=6.53e-10 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | MARK3 | 0.12 | 0.05 | lasso | 3 | 0.06 | 2.5e-05 | 5.2 | 5.1 | 2.7e-07 | 0.69 | 0.16 | 0.81 | FALSE |
2 | GTEx | Adipose Visceral Omentum | KLC1 | 0.06 | 0.02 | lasso | 2 | 0.00 | 2.2e-01 | 5.0 | -5.5 | 2.9e-08 | -0.57 | 0.15 | 0.08 | FALSE |
3 | GTEx | Adrenal Gland | KLC1 | 0.15 | 0.03 | lasso | 3 | 0.06 | 4.6e-03 | -4.8 | -5.9 | 3.2e-09 | -0.52 | 0.12 | 0.25 | FALSE |
4 | GTEx | Artery Aorta | KLC1 | 0.10 | 0.14 | lasso | 3 | 0.14 | 6.1e-08 | 5.0 | -5.5 | 3.8e-08 | -0.59 | 0.57 | 0.42 | FALSE |
5 | GTEx | Artery Tibial | TRMT61A | 0.07 | 0.07 | lasso | 3 | 0.06 | 2.4e-05 | 5.1 | 5.9 | 4.3e-09 | 0.84 | 0.02 | 0.98 | FALSE |
6 | GTEx | Breast Mammary Tissue | MARK3 | 0.12 | 0.11 | lasso | 2 | 0.08 | 3.9e-05 | 5.3 | 5.3 | 9.2e-08 | 0.69 | 0.14 | 0.79 | FALSE |
7 | GTEx | Breast Mammary Tissue | KLC1 | 0.12 | 0.02 | enet | 26 | 0.07 | 2.9e-04 | -4.5 | -5.2 | 2.1e-07 | -0.41 | 0.84 | 0.05 | FALSE |
8 | GTEx | Breast Mammary Tissue (Male) | MARK3 | 0.08 | 0.00 | enet | 9 | -0.01 | 7.2e-01 | 5.3 | 6.2 | 4.3e-10 | 0.66 | 0.03 | 0.38 | FALSE |
9 | GTEx | Cells Transformed fibroblasts | ZFYVE21 | 0.10 | 0.03 | lasso | 4 | 0.11 | 1.1e-08 | 5.1 | -5.1 | 2.7e-07 | -0.56 | 0.29 | 0.49 | FALSE |
10 | GTEx | Cells Transformed fibroblasts | APOPT1 | 0.14 | 0.12 | lasso | 3 | 0.10 | 6.4e-08 | 4.9 | 5.5 | 3.0e-08 | 0.57 | 0.63 | 0.37 | FALSE |
11 | GTEx | Esophagus Mucosa | KLC1 | 0.17 | 0.09 | lasso | 5 | 0.12 | 1.6e-08 | -4.8 | -5.3 | 8.9e-08 | -0.42 | 0.84 | 0.14 | FALSE |
12 | GTEx | Esophagus Muscularis | ZFYVE21 | 0.11 | 0.06 | lasso | 5 | 0.05 | 5.7e-04 | 4.8 | -5.2 | 2.3e-07 | -0.61 | 0.41 | 0.34 | FALSE |
13 | GTEx | Esophagus Muscularis | KLC1 | 0.07 | 0.01 | enet | 10 | 0.02 | 2.6e-02 | 5.0 | -5.4 | 5.5e-08 | -0.58 | 0.10 | 0.53 | FALSE |
14 | GTEx | Lung | MARK3 | 0.06 | 0.02 | lasso | 3 | 0.01 | 6.6e-02 | 5.3 | 5.8 | 6.8e-09 | 0.77 | 0.04 | 0.90 | FALSE |
15 | GTEx | Lung | CKB | 0.07 | 0.01 | lasso | 2 | 0.01 | 3.4e-02 | 5.0 | 5.6 | 2.1e-08 | 0.71 | 0.07 | 0.80 | FALSE |
16 | GTEx | Pituitary | MARK3 | 0.21 | 0.27 | enet | 8 | 0.25 | 4.9e-07 | 5.3 | 5.5 | 3.4e-08 | 0.70 | 0.13 | 0.79 | FALSE |
17 | GTEx | Prostate | MARK3 | 0.18 | 0.22 | enet | 11 | 0.20 | 8.0e-06 | 5.3 | 5.2 | 2.0e-07 | 0.69 | 0.18 | 0.63 | FALSE |
18 | GTEx | Skin Not Sun Exposed Suprapubic | MARK3 | 0.16 | 0.10 | lasso | 3 | 0.10 | 6.7e-06 | 5.3 | 5.4 | 5.8e-08 | 0.67 | 0.16 | 0.83 | FALSE |
19 | GTEx | Skin Not Sun Exposed Suprapubic | CKB | 0.28 | 0.26 | lasso | 4 | 0.25 | 6.4e-14 | 6.1 | 6.2 | 7.3e-10 | 0.98 | 0.00 | 1.00 | FALSE |
20 | GTEx | Skin Sun Exposed Lower leg | MARK3 | 0.10 | 0.09 | enet | 13 | 0.08 | 7.5e-07 | 5.2 | 5.4 | 7.9e-08 | 0.76 | 0.16 | 0.84 | FALSE |
21 | GTEx | Skin Sun Exposed Lower leg | CKB | 0.43 | 0.32 | enet | 16 | 0.34 | 5.9e-29 | 6.1 | 6.1 | 1.3e-09 | 0.96 | 0.00 | 1.00 | FALSE |
22 | GTEx | Stomach | MARK3 | 0.10 | 0.09 | lasso | 2 | 0.04 | 4.5e-03 | 5.3 | 5.3 | 1.2e-07 | 0.68 | 0.16 | 0.53 | FALSE |
23 | GTEx | Stomach | TRMT61A | 0.12 | 0.11 | lasso | 5 | 0.08 | 1.2e-04 | 5.3 | 5.3 | 8.9e-08 | 0.69 | 0.12 | 0.78 | FALSE |
24 | GTEx | Thyroid | MARK3 | 0.38 | 0.48 | lasso | 4 | 0.48 | 2.8e-41 | 5.3 | 5.3 | 1.0e-07 | 0.69 | 0.20 | 0.80 | FALSE |
25 | YFS | Blood | KLC1 | 0.01 | 0.01 | blup | 389 | 0.01 | 1.0e-03 | 4.5 | -6.1 | 1.1e-09 | -0.61 | 0.26 | 0.32 | FALSE |
26 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CKB | 0.06 | 0.03 | lasso | 3 | 0.03 | 2.5e-06 | 6.2 | 6.0 | 1.6e-09 | 0.98 | 0.00 | 1.00 | FALSE |
27 | The Cancer Genome Atlas | Glioblastoma Multiforme | C14orf153 | 0.14 | 0.01 | blup | 40 | 0.03 | 3.5e-02 | 4.8 | 5.2 | 1.8e-07 | 0.73 | 0.00 | 0.45 | FALSE |
28 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | MARK3 | 0.07 | 0.03 | blup | 64 | 0.06 | 5.5e-07 | 6.1 | 5.5 | 3.3e-08 | 0.85 | 0.00 | 0.99 | FALSE |
29 | The Cancer Genome Atlas | Lung Adenocarcinoma | C14orf153 | 0.06 | 0.02 | blup | 38 | 0.04 | 2.4e-05 | 4.8 | 5.3 | 1.4e-07 | 0.54 | 0.03 | 0.86 | FALSE |
30 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | BAG5 | 0.08 | 0.09 | lasso | 2 | 0.08 | 3.7e-04 | 5.3 | 5.3 | 1.2e-07 | 0.69 | 0.00 | 0.96 | FALSE |
31 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C14orf153 | 0.09 | 0.08 | blup | 38 | 0.09 | 6.2e-10 | 4.9 | 5.6 | 2.2e-08 | 0.64 | 0.02 | 0.98 | FALSE |
32 | The Cancer Genome Atlas | Prostate Adenocarcinoma | MARK3 | 0.07 | 0.06 | enet | 7 | 0.08 | 1.0e-08 | 6.2 | 6.3 | 3.3e-10 | 0.95 | 0.00 | 1.00 | TRUE |
33 | The Cancer Genome Atlas | Thyroid Carcinoma | MARK3 | 0.10 | 0.03 | blup | 61 | 0.03 | 4.0e-04 | 6.1 | 5.7 | 9.2e-09 | 0.74 | 0.01 | 0.76 | FALSE |